Research and Clinical Trials

Using advanced technology, scientists at Mayo Clinic, Chan Zuckerberg (CZ) Biohub and the University of California San Francisco (UCSF), have discovered an autoimmune disease that[...]

According to new research from Mayo Clinic, colorectal cancer outcomes may improve by genetically altering an immune-regulatory protein in cancer cells, making the cells more[...]

Mayo Clinic has opened a new 190,000-square-foot medical building on its Florida campus for patients seeking cancer, neurology and neurosurgical care. Named in honor of[...]

Daniel D. Billadeau, Ph.D., an oncology researcher at Mayo Clinic in Rochester, Minnesota, talks about his work investigating pancreatic cancer. Dr. Billadeau is also a principal investigator of the Mayo Clinic Pancreatic Cancer SPORE.

Researchers from Mayo Clinic are evaluating a new, noninvasive screening method for Barrett's esophagus that uses an electronic nose device called an e-nose to analyze[...]

Donald W. Northfelt, M.D., an oncologist and breast cancer researcher at Mayo Clinic in Phoenix, Arizona, talks about his research, his mentors and promoting equity in clinical trials.

Results of a study on smoldering multiple myeloma presented at the 2019 American Society of Clinical Oncology Annual Meeting suggest that the cancer drug lenalidomide[...]

Studies show that the risk of breast cancer can be reduced by half through the use of a five-year course of tamoxifen or raloxifene and[...]

A new Mayo Clinic study suggests that some patients with pancreatic cancer could increase survival with adjustments to their chemotherapy regimen before surgery. Historically, most[...]

The percentage of women who are screened for cervical cancer may actually be far lower than national statistics suggest they are, according to a Mayo[...]